Medical/Pharmaceuticals

Beyang Closes Oversubscribed $30 Million Series A Financing

Funding to accelerate the iteration of the proprietary AI-driven ExCEED platform and advance global clinical development of differentiated pipelines, including a second-generation Menin inhibitor and a novel ophthalmic therapy. CHENGDU, China, Aug. 12, 2026 /PRNewswire/ -- Beyang Therapeutics Co....

2026-08-12 17:10 3262

Introducing Oticon Reveal™ - the world's first hearing aid powered by Dual AI

From only words to a richer world of sound SMØRUM, Denmark, Aug. 12, 2026 /PRNewswire/ -- Today, Oticon launches Oticon Reveal™, the world's first hearing aid powered by Dual AI, delivering crystal-clear speech and meaningful sounds in optimal balance, bringing hearing aid users closer to a natu...

2026-08-12 14:00 3255

Metabolon Launches Peak Science Grant Program to Advance Breakthrough Metabolomics Research

Quarterly grant program provides researchers with no-cost access to Metabolon's industry-leading metabolomics platform, scientific expertise, bioinformatics tools, and data interpretation resources MORRISVILLE, N.C., Aug. 11, 2026 /PRNewswire/ -- Metabolon, Inc., the global leader in metabolomic...

2026-08-11 21:00 1907

Bracco Marks Major Global Milestone with U.S. FDA 510(k) Clearance and Health Canada Authorization for VueJect®, the First Dedicated Ultrasound Contrast Delivery System to Support Cardiology Imaging

VueJect® strengthens Bracco's integrated CEUS ecosystem by enabling more standardized, efficient contrast administration in cardiology imaging MILAN, Aug. 11, 2026 /PRNewswire/ -- Bracco Imaging today announced that VueJect®, its first dedicated ultrasound contrast delivery system engineered to ...

2026-08-11 20:00 2415

Korean Biotech Company K-Medichem Expands Global Market Reach with PDRN Derma Skincare Line in Vietnam, Indonesia and Beyond

* PDRN Derma cream, serum, and mask lineup positions premium K-dermocosmetics based on patented ingredients for Southeast Asian market expansion CHUNCHEON, South Korea, Aug. 11, 2026 /PRNewswire/ -- K-Medichem Co., Ltd. (K-Medichem), a Korean biotech company built on university research, is acc...

2026-08-11 19:17 3219

Cambrex Milan Celebrates 80th Anniversary with Construction of New $30 Million R&D Facility

EAST RUTHERFORD, N.J., Aug. 11, 2026 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), today announced the start of construction on a new research and development (R&D) facility at its Milan, Italy site. This $30 million investment will add adva...

2026-08-11 18:00 2511

Haleon and Singapore's Agency for Science, Technology and Research (A*STAR) Launch New Clinical Study on Women's Metabolic Health in Asia

* A new clinical study on the multivitamin and mineral supplement Centrum is designed to generate evidence on metabolic health in midlife Asian women - a group often underrepresented in global nutrition research. * The study will contribute to a better understanding of preventive healthcare a...

2026-08-11 11:41 2626

Global Study Results Published in Aesthetic Surgery Journal Open Forum Show Link Between Self-Confidence and Aesthetics

Publication in the peer-reviewed journal reinforces the study's insights and validates what clinicians frequently observe – that the impact of aesthetic treatments extends beyond physical appearance.  * The Pillars of Confidence Global Study, supported by Merz Aesthetics, evaluated the impact ...

2026-08-11 10:00 2100

Lifespan Vision Ventures Leads Remedium Bio's Series A Financing

Investment supports advancement of Remedium's durable protein therapeutics platform toward first-in-human clinical development. NORWALK, Conn., Aug. 10, 2026 /PRNewswire/ -- Lifespan Vision Ventures today announced that it is leading Remedium Bio, Inc.'s ("Remedium") $10 million Series A financi...

2026-08-10 22:00 2794

Unveiling a Smarter Future for Dentistry at China Dental Show 2026

AI-powered clinical solutions, hands-on experiences and global business opportunities will come together in Shanghai from October 13 to 16 SHANGHAI, Aug. 10, 2026 /PRNewswire/ -- China Dental Show 2026 (CDS 2026) will take place from October 13 to 16 at the National Exhibition and Convention Cen...

2026-08-10 21:00 3253

NYSE Content Update: Goldman Sachs Asset Management Launches Two New ETFs

NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, Aug. 10, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begin...

2026-08-10 20:56 5956

Ascletis Announces Initiation of Two Phase I Studies in U.S. for the Treatment of Obesity: ASC36 Once-Monthly Injection, an Amylin Receptor Peptide Agonist, and ASC36_35FDC Once-Monthly Injection, a Co-Formulation of ASC36 and GLP-1R/GIPR Peptide Agonist ASC35

-ASC36_35FDC, a once-monthly subcutaneous (SQ) fixed dose combination (FDC) injection of ASC36 and ASC35, is a potentially first-in-class drug candidate which targets three validated targets of amylin receptor, GLP-1R and GIPR. -ASC36 is a potentially first-in-class once-monthly to once-quarterly...

2026-08-10 19:00 4765

Dx&Vx Signs Two Material Transfer Agreements in Latin America Within Two Months -- "Technology Validated Across Both Public and Private Sectors"

— Argentine biopharmaceutical company in July, South American public health institution in August sign consecutive KRNA material transfer agreements — Two of five cumulative MTAs now in Latin America, as company accelerates entry into the region's pharmaceutical market SEOUL, South Korea, Aug. 10...

2026-08-10 17:36 3262

/C O R R E C T I O N -- United Imaging/

In the news release, Chinese and Indonesian cardiologists complete Southeast Asia's first "noise-free" cardiac procedure in Jakarta, issued 09-Aug-2026 by United Imaging over PR Newswire, the 2nd paragraph, 1st sentence, should read "The procedure, performed recently" rather than "The procedure, ...

2026-08-10 16:45 4728

2026 Global Health Summit Opens in Hong Kong -- Global Healthcare Leaders Convene: Bringing Breakthroughs to Patients

HONG KONG, Aug. 10, 2026 /PRNewswire/ -- The 2026 Global Health Summit ("GHS 2026"), jointly hosted by New Frontier Group ("New Frontier") and the Hong Kong Investment Corporation Limited ("HKIC"), opened today at the Hong Kong Convention and Exhibition Centre for a two-day programme. Held under ...

2026-08-10 11:00 811

Alebund's AP301 NDA Accepted for Review by China's NMPA

SHANGHAI, Aug. 7, 2026 /PRNewswire/ -- Alebund Pharmaceuticals (Jiangsu) Limited ("Alebund" or the "Company"; HKEX: 09637), a renal-focused biopharmaceutical company, today announced that the New Drug Application (NDA) for AP301 capsules, a novel oral iron-based phosphate binder, for the treatmen...

2026-08-07 18:40 3433

Check out Hainan's Pioneering Medical Hub

Uncover the New Charms of Boao Lecheng Medical Tourism HAIKOU, China, Aug. 7, 2026 /PRNewswire/ -- A news report from PDDC: Coastal scenery soothes body and mind, while cutting‑edge medical services empower health‑and‑wellness tourism. Bolstered by the opening‑up dividends of Hainan Free Trade P...

2026-08-07 18:27 2946

CLASSYS Appoints Former Samsung Electronics and Vuno Executive Dr. Taek-Soo Kim as Chief Technology Officer, Accelerating Its Evolution into a Global Medical Aesthetics Technology Company

SEOUL, South Korea, Aug. 7, 2026 /PRNewswire/ -- CLASSYS (KOSDAQ: 214150), a global medical aesthetics platform company, announced the appointment of Dr. Taek-Soo Kim, a distinguished technology management expert, as its new Chief Technology Officer (CTO) and Head of Research and Development. ...

2026-08-07 08:16 5148

Immune Mediated Disease Therapeutics Developer Attovia Therapeutics Debuts on Nasdaq

SHANGHAI, Aug. 6, 2026 /PRNewswire/ -- Attovia Therapeutics, a portfolio company of Qiming Venture Partners and clinical-stage biopharmaceutical leader, successfully listed on the Nasdaq on August 5, 2026 Beijing time. Attovia Therapeutics (Nasdaq: ATTO) issued shares at a price of $17.00 per sha...

2026-08-06 18:46 4162

Chugai Pharma Taiwan (CPT) Secures Dual Recognition at the Asia Responsible Enterprise Awards (AREA) for Health Promotion and Green Leadership Initiatives

SINGAPORE, Aug. 6, 2026 /PRNewswire/ -- Chugai Pharma Taiwan (CPT) was recognized at the Asia Responsible Enterprise Awards (AREA) 2026organised by Enterprise Asia under the Health Promotion and Green Leadership categories for its integrated ESG approach that advances human health, employee well-...

2026-08-06 15:11 3205
1 ... 9101112131415 ... 381